Open innovation in neuroscience research and drug discovery
The pressures on the pharmaceutical industry have incentivised a number of new collaborative models of research and development which can be categorised as open innovation. Examples of the different types of models employed are discussed and some, but not all, of these have been used to promote rese...
| Príomhchruthaitheoirí: | , , |
|---|---|
| Formáid: | Journal article |
| Teanga: | English |
| Foilsithe / Cruthaithe: |
SAGE Publications
2018
|
| _version_ | 1826275529924280320 |
|---|---|
| author | Hunter, A Lee, W Bountra, C |
| author_facet | Hunter, A Lee, W Bountra, C |
| author_sort | Hunter, A |
| collection | OXFORD |
| description | The pressures on the pharmaceutical industry have incentivised a number of new collaborative models of research and development which can be categorised as open innovation. Examples of the different types of models employed are discussed and some, but not all, of these have been used to promote research and drug discovery for central nervous system disorders. Some are completely open access, while others have some intellectual property restrictions. Going forward, more ways of promoting open innovation and the sharing of best practice, especially in the neurosciences, will stimulate research and hopefully accelerate new medicines development. |
| first_indexed | 2024-03-06T23:00:06Z |
| format | Journal article |
| id | oxford-uuid:61d32d1e-55a5-4b60-b72f-2a0cee095ca3 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T23:00:06Z |
| publishDate | 2018 |
| publisher | SAGE Publications |
| record_format | dspace |
| spelling | oxford-uuid:61d32d1e-55a5-4b60-b72f-2a0cee095ca32022-03-26T18:02:19ZOpen innovation in neuroscience research and drug discoveryJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:61d32d1e-55a5-4b60-b72f-2a0cee095ca3EnglishSymplectic Elements at OxfordSAGE Publications2018Hunter, ALee, WBountra, CThe pressures on the pharmaceutical industry have incentivised a number of new collaborative models of research and development which can be categorised as open innovation. Examples of the different types of models employed are discussed and some, but not all, of these have been used to promote research and drug discovery for central nervous system disorders. Some are completely open access, while others have some intellectual property restrictions. Going forward, more ways of promoting open innovation and the sharing of best practice, especially in the neurosciences, will stimulate research and hopefully accelerate new medicines development. |
| spellingShingle | Hunter, A Lee, W Bountra, C Open innovation in neuroscience research and drug discovery |
| title | Open innovation in neuroscience research and drug discovery |
| title_full | Open innovation in neuroscience research and drug discovery |
| title_fullStr | Open innovation in neuroscience research and drug discovery |
| title_full_unstemmed | Open innovation in neuroscience research and drug discovery |
| title_short | Open innovation in neuroscience research and drug discovery |
| title_sort | open innovation in neuroscience research and drug discovery |
| work_keys_str_mv | AT huntera openinnovationinneuroscienceresearchanddrugdiscovery AT leew openinnovationinneuroscienceresearchanddrugdiscovery AT bountrac openinnovationinneuroscienceresearchanddrugdiscovery |